Coherence Neuro

United Kingdom
Cambridge, England, United Kingdom

Company profile

Coherence Neuro company profile

Coherence specializes in the development of innovative healthcare technologies that bridge the gap between cancer neuroscience and bioelectronics. The company focuses on creating smaller, softer, and wireless biological interfaces designed to offer a new treatment modality. By leveraging advancements in neural engineering and bioelectronics, Coherence is dedicated to building new tools that interface with the body, aiming to improve patient outcomes in the healthcare sector.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2022-01-01, Year

Headquarters

Country code
GB
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
2
Total equity funding
$12.3M
Last funding
Seed / $10M / 2025-11-03
Last equity funding
Seed / $10M
Investors
14
Lead investors
3
Founders
2
Articles
3

Founders and investors

Founders

Ben WoodingtonElise Jenkins

Lead investors

Artesian VCBlackbird Venturestopology

Investors

Artesian VCBlackbird VenturesPossible VenturesSmartGateVCtopology